CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Martin, Fernando L ^a   Sangaralingham, S Jeson ^a   Huntley, Brenda K ^a   McKie, Paul M ^a   Ichiki, Tomoko ^a   Chen, Horng H ^a   Korinek, Josef ^a   Harders, Gerald E ^a   Burnett, John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CENDERITIDE; CYCLIC GMP; GUANYLATE CYCLASE ACTIVATOR; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLE; DRUG MECHANISM; HEART LEFT VENTRICLE FIBROSIS; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NONHUMAN; RAT; SECOND MESSENGER; SYSTOLE; TREATMENT DURATION;

ALDOSTERONE; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CYCLIC GMP; ELAPID VENOMS; FIBROSIS; HEART; HEART VENTRICLES; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MYOCARDIUM; NATRIURETIC PEPTIDE, C-TYPE; RATS; RECEPTORS, GUANYLATE CYCLASE-COUPLED;

RATTUS;

EID: 84871315815     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052422     Document Type: Article

References (32)

1. Lowe DG, Chang MS, Hellmiss R, Chen E, Singh S, et al. (1989) Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. Embo J 8: 1377-1384.
2. Potter LR, Abbey-Hosch S, Dickey DM, (2006) Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27: 47-72.
3. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, et al. (1991) Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252: 120-123.
4. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, et al. (1992) Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130: 229-239.
5. Dickey DM, Burnett JC Jr, Potter LR, (2008) Novel bifunctional natriuretic peptides as potential therapeutics. J Biol Chem 283: 35003-35009.
6. Lisy O, Huntley BK, McCormick DJ, Kurlansky PA, Burnett JC Jr, (2008) Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. J Am Coll Cardiol 52: 60-68.
7. Horio T, Tokudome T, Maki T, Yoshihara F, Suga S, et al. (2003) Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology 144: 2279-2284.
8. Dickey DM, Potter LR, (2011) Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation. J Mol Cell Cardiol 51: 67-71.
9. Schweitz H, Vigne P, Moinier D, Frelin C, Lazdunski M, (1992) A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). J Biol Chem 267: 13928-13932.
10. Lee CY, Chen HH, Lisy O, Swan S, Cannon C, et al. (2009) Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects. J Clin Pharmacol 49: 668-673.
11. Murakami S, Nagaya N, Itoh T, Fujii T, Iwase T, et al. (2004) C-type natriuretic peptide attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 287: L1172-1177.
12. Soeki T, Kishimoto I, Okumura H, Tokudome T, Horio T, et al. (2005) C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J Am Coll Cardiol 45: 608-616.
13. Martin FL, McKie PM, Cataliotti A, Sangaralingham SJ, Korinek J, et al. (2012) Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection. Am J Physiol Regul Integr Comp Physiol 302: R292-299.
14. Tsuruda T, Boerrigter G, Huntley BK, Noser JA, Cataliotti A, et al. (2002) Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 91: 1127-1134.
15. Steiner AL, Parker CW, Kipnis DM, (1970) The measurement of cyclic nucleotides by radioimmunoassay. Adv Biochem Psychopharmacol 3: 89-111.
16. Sangaralingham SJ, Huntley BK, Martin FL, McKie PM, Bellavia D, et al. (2011) The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic peptide. Hypertension 57: 201-207.
17. Sangaralingham SJ, Ritman EL, McKie PM, Ichiki T, Lerman A, et al. (2012) Cardiac micro-computed tomography imaging of the aging coronary vasculature. Circ Cardiovasc Imaging 5: 518-524.
18. Mayes D, Furuyama S, Kem DC, Nugent CA, (1970) A radioimmunoassay for plasma aldosterone. J Clin Endocrinol Metab 30: 682-685.
19. Surendran K, Simon TC, (2003) CNP gene expression is activated by Wnt signaling and correlates with Wnt4 expression during renal injury. Am J Physiol Renal Physiol 284: F653-662.
20. Hu P, Wang J, Hu B, Lu L, Xuan Q, et al. (2012) Increased urinary C-type natriuretic peptide excretion may be an early marker of renal tubulointerstitial fibrosis. Peptides. 37: 98-105.
21. Sangaralingham SJ, Heublein DM, Grande JP, Cataliotti A, Rule AD, et al. (2011) Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging. Am J Physiol Renal Physiol 301: F943-952.
22. Peltonen TO, Taskinen P, Soini Y, Rysa J, Ronkainen J, et al. (2007) Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis. Circulation 116: 1283-1289.
23. Kenny AJ, Bourne A, Ingram J, (1993) Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem J 291 (Pt 1): 83-88.
24. Hunt PJ, Richards AM, Espiner EA, Nicholls MG, Yandle TG, (1994) Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab 78: 1428-1435.
25. Weber KT, Brilla CG, (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83: 1849-1865.
26. Burniston JG, Saini A, Tan LB, Goldspink DF, (2005) Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo. J Mol Cell Cardiol 39: 395-399.
27. Mano A, Tatsumi T, Shiraishi J, Keira N, Nomura T, et al. (2004) Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways. Circulation 110: 317-323.
28. Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM, (2006) Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J 20: 1546-1548.
29. Young MJ, (2008) Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Curr Opin Nephrol Hypertens 17: 174-180.
30. Brilla CG, (2000) Renin-angiotensin-aldosterone system and myocardial fibrosis. Cardiovasc Res 47: 1-3.
31. Kato T, Muraski J, Chen Y, Tsujita Y, Wall J, et al. (2005) Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest 115: 2716-2730.
32. Doyle DD, Upshaw-Earley J, Bell EL, Palfrey HC, (2002) Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population. Am J Physiol Heart Circ Physiol 282: H2117-2123.